Becton Dickinson Resultados de beneficios anteriores
Pasado controles de criterios 1/6
Becton Dickinson ha aumentado sus beneficios a una tasa media anual de 13.5%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 13.5% anual. Los ingresos han ido creciendo a una tasa media de 3% al año. La rentabilidad financiera de Becton Dickinson es de 5.1%, y sus márgenes netos son de 6.5%.
Información clave
12.6%
Tasa de crecimiento de los beneficios
11.4%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | 8.9% |
| Tasa de crecimiento de los ingresos | 3.1% |
| Rentabilidad financiera | 5.4% |
| Margen neto | 6.9% |
| Última actualización de beneficios | 31 Mar 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?
May 24
Becton, Dickinson and Company: Stagnating All Along
May 16Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)
Mar 23Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)
Feb 29Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings
Feb 08Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 03These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well
Feb 01Becton, Dickinson: 4 Reasons To Buy This Growth At A Reasonable Price Play
Jan 22Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 30Becton, Dickinson And Company: Strong Q4 But Clouded By 75bps Growth Headwind From China In FY24
Nov 13Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's
Nov 12Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price
Nov 06With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case
Oct 05Becton, Dickinson Stock Is A Hold, Here's Why
Oct 04Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers
Aug 30We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt
Aug 13Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Jul 28Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching
Jun 22Becton, Dickinson and Company: Still Not Very Healthy
Jun 20Becton, Dickinson: Business Should Beat H2 2023 Expectations
Jun 08These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well
Apr 22Is Now The Time To Put Becton Dickinson (NYSE:BDX) On Your Watchlist?
Mar 20Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Mar 05Becton, Dickinson HPV test Onclarity gets FDA nod for expanded use
Feb 21Becton, Dickinson wins FDA nod for flu, COVID, RSV combo test
Feb 08Becton, Dickinson Q1 2023 Earnings Preview
Feb 01Becton, Dickinson declares $0.91 dividend
Jan 24We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt
Jan 09CerTest/Becton, Dickinson's test for monkeypox gets FDA emergency use nod
Jan 09Becton, Dickinson: A Quality Defensive Pick For 2023
Dec 20Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Dec 01Becton Dickinson (NYSE:BDX) Is Increasing Its Dividend To $0.91
Nov 13Becton, Dickinson Q4 2022 Earnings Preview
Nov 09Becton, Dickinson, Biocorp team up for traceability of injectable drugs
Oct 18Becton, Dickinson: Buy In Now While You Can
Oct 12Desglose de ingresos y gastos
Cómo gana y gasta dinero Becton Dickinson. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 24 | 19,716 | 1,364 | 4,829 | 1,175 |
| 31 Dec 23 | 19,492 | 1,265 | 4,843 | 1,214 |
| 30 Sep 23 | 19,372 | 1,470 | 4,817 | 1,237 |
| 30 Jun 23 | 19,046 | 1,582 | 4,848 | 1,256 |
| 31 Mar 23 | 18,809 | 1,556 | 4,791 | 1,266 |
| 31 Dec 22 | 18,738 | 1,486 | 4,751 | 1,255 |
| 30 Sep 22 | 18,870 | 1,545 | 4,726 | 1,256 |
| 30 Jun 22 | 18,958 | 1,412 | 4,774 | 1,324 |
| 31 Mar 22 | 18,924 | 1,430 | 4,845 | 1,339 |
| 31 Dec 21 | 18,534 | 1,079 | 4,750 | 1,302 |
| 30 Sep 21 | 19,131 | 1,514 | 4,720 | 1,279 |
| 30 Jun 21 | 19,066 | 1,486 | 4,632 | 1,210 |
| 31 Mar 21 | 18,313 | 1,379 | 4,409 | 1,142 |
| 31 Dec 20 | 18,207 | 1,507 | 4,346 | 1,117 |
| 30 Sep 20 | 16,074 | 245 | 4,178 | 1,039 |
| 30 Jun 20 | 16,917 | 786 | 4,216 | 1,067 |
| 31 Mar 20 | 17,414 | 923 | 4,313 | 1,057 |
| 31 Dec 19 | 17,355 | 760 | 4,379 | 1,044 |
| 30 Sep 19 | 17,290 | 1,081 | 4,334 | 1,032 |
| 30 Jun 19 | 17,108 | 784 | 4,345 | 1,039 |
| 31 Mar 19 | 17,036 | 926 | 4,353 | 1,063 |
| 31 Dec 18 | 17,063 | 894 | 4,325 | 1,071 |
| 30 Sep 18 | 15,983 | 159 | 4,029 | 1,004 |
| 30 Jun 18 | 14,747 | 621 | 3,689 | 947 |
| 31 Mar 18 | 13,503 | -99 | 3,325 | 857 |
| 31 Dec 17 | 12,251 | 294 | 2,991 | 783 |
| 30 Sep 17 | 12,093 | 1,030 | 2,953 | 770 |
| 30 Jun 17 | 12,158 | 759 | 2,947 | 807 |
| 31 Mar 17 | 12,321 | 1,314 | 2,957 | 827 |
| 31 Dec 16 | 12,419 | 1,309 | 2,966 | 823 |
| 30 Sep 16 | 12,483 | 976 | 3,005 | 828 |
| 30 Jun 16 | 12,312 | 1,139 | 2,966 | 771 |
| 31 Mar 16 | 12,234 | 810 | 2,988 | 743 |
| 31 Dec 15 | 11,217 | 688 | 2,767 | 690 |
| 30 Sep 15 | 10,282 | 695 | 2,563 | 632 |
| 30 Jun 15 | 9,410 | 815 | 2,350 | 570 |
| 31 Mar 15 | 8,448 | 1,079 | 2,127 | 529 |
| 31 Dec 14 | 8,468 | 1,150 | 2,141 | 527 |
| 30 Sep 14 | 8,446 | 1,185 | 2,145 | 524 |
| 30 Jun 14 | 8,345 | 974 | 2,117 | 522 |
| 31 Mar 14 | 8,239 | 941 | 2,102 | 506 |
| 31 Dec 13 | 8,169 | 930 | 2,091 | 502 |
| 30 Sep 13 | 8,054 | 929 | 2,059 | 494 |
| 30 Jun 13 | 7,920 | 1,114 | 2,004 | 490 |
Ingresos de calidad: BDX tiene un gran one-off loss de $709.0M impacto en sus últimos 12 meses de resultados financieros a 31st December, 2023.
Margen de beneficios creciente: Los actuales márgenes de beneficio(6.5%) de BDX son inferiores a los del año pasado (7.9%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de BDX han crecido un 13.5% al año en los últimos 5 años.
Acelerando crecimiento: BDX ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: BDX tuvo un crecimiento negativo de los beneficios (-14.9%) durante el año pasado, lo que dificulta la comparación con la media de la industria Medical Equipment (3.3%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de BDX (5.1%) se considera baja.